Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2005

Conditions
LymphedemaPerioperative/Postoperative ComplicationsVulvar Cancer
Interventions
DRUG

fibrin sealant

PROCEDURE

surgical wound closure

Trial Locations (49)

10021

Memorial Sloan-Kettering Cancer Center, New York

19111

Fox Chase-Temple Cancer Center, Philadelphia

19713

CCOP - Christiana Care Health Services, Newark

27710

Duke Comprehensive Cancer Center, Durham

35294

Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham

37917

Southeast Gynecologic Oncology Associates, Knoxville

44124

Cleveland Clinic Taussig Cancer Center, Cleveland

46617

Saint Joseph Regional Medical Center, South Bend

48106

CCOP - Michigan Cancer Research Consortium, Ann Arbor

49503

CCOP - Grand Rapids, Grand Rapids

55416

CCOP - Metro-Minnesota, Saint Louis Park

55455

University of Minnesota Cancer Center, Minneapolis

60201

CCOP - Evanston, Evanston

60612

MBCCOP - University of Illinois at Chicago, Chicago

61801

CCOP - Carle Cancer Center, Urbana

64131

CCOP - Kansas City, Kansas City

65203

Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia

65807

CCOP - Cancer Research for the Ozarks, Springfield

68106

CCOP - Missouri Valley Cancer Consortium, Omaha

73104

University of Oklahoma College of Medicine, Oklahoma City

73190

Oklahoma University Medical Center, Oklahoma City

76508

CCOP - Scott and White Hospital, Temple

80010

University of Colorado Cancer Center at University of Colorado Health Sciences Center, Denver

92868

Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange

97225

CCOP - Columbia River Oncology Program, Portland

98405

MultiCare Regional Cancer Center at Tacoma General Hospital, Tacoma

85006-2726

CCOP - Western Regional, Arizona, Phoenix

90095-1740

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

20307-5001

Walter Reed Army Medical Center, Washington D.C.

62794-9640

CCOP - Central Illinois, Decatur

52242-1002

Holden Comprehensive Cancer Center at University of Iowa, Iowa City

49007-3731

CCOP - Kalamazoo, Kalamazoo

55905-0001

Mayo Clinic Cancer Center, Rochester

39216-4505

University of Mississippi Medical Center, Jackson

39534-2576

Keesler Medical Center - Keesler Air Force Base, Keesler Air Force Base

08103-1489

Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees, Camden

14263-0001

Roswell Park Cancer Institute, Buffalo

11790-7775

Long Island Cancer Center at Stony Brook University Hospital, Stony Brook

27599-7570

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

27157-1065

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

45267-0520

Charles M. Barrett Cancer Center at University Hospital, Cincinnati

43210-1240

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus

19001-3788

Abington Memorial Hospital, Abington

17822-2001

CCOP - Geisinger Clinic and Medical Center, Danville

15213-3180

UPMC Cancer Center at Magee-Womens Hospital, Pittsburgh

37232-2516

Vanderbilt-Ingram Cancer Center, Nashville

77555-0587

University of Texas Medical Branch, Galveston

77030-4009

M.D. Anderson Cancer Center at University of Texas, Houston

05401

Fletcher Allen Health Care - Medical Center Hospital of Vermont Campus, Burlington

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00028951 - Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva | Biotech Hunter | Biotech Hunter